Skip to main content
OpenTrials
Completed

NCT Number: NCT01166464

Examining a Text Message Intervention for Smoking Cessation

The primary goal of this study is to use qualitative interviews and focus groups to aid us in adapting a face-to-face smoking cessation intervention for delivery through text messaging. After design is completed, the intervention will be pilot tested with a sample of young adults (ages 18-35) who smoke. Final assessments will be conducted at 7 weeks (end of treatment) and both 3 and 6 month follow up.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Use Disorder Behavior Chemically-Induced Disorders Mental Disorders Nicotine Dependence Smoking Substance-Related Disorders

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Miriam Hospital

Providence, Rhode Island, 02903, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 35
  • Current daily smoker
  • Has a cell phone with text messaging capability
  • Uses text messaging at least once monthly
  • Interested in quitting smoking
  • Willing to set a quit date within the next 30 days
  • Has access to a physician

Exclusion criteria

  • Does not read and speak English with adequate comprehension
  • Is currently participating in a smoking cessation program
  • Concurrent drug/alcohol abuse
  • Mental health issues that would interfere with study compliance

Treatment and study plan

text messaging for smoking cessation

Behavioral

A 7-week program of daily text messages

Generic text messages

Behavioral

non-smoking related text messages will be given on the same daily schedule as matches the active intervention to establish a control for contact time.

Primary outcomes

  1. Smoking abstinence

    Time frame: Six months post-treatment

    7-day point prevalence abstinence will be measured at 6 months post-treatment.

Secondary outcomes

  1. Usability and Acceptability of the intervention

    Time frame: 7 weeks (end of treatment)

    Usability and acceptability of the intervention will be assessed at the end of treatment (week 7).

Sponsors and collaborators

Lead sponsor

The Miriam Hospital

Other

Collaborators

  • Live Inspired, LLC

Registry information

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jul 21, 2010
Registry last updated
Feb 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.